University of Cincinnati College of Medicine

George L. Strike Bone Marrow Transplant Program

Cincinnati, OH

Sorting 2 by

Accepting patients

VIP943

An Open-label, Multicenter Phase 1 Study to Characterize Safety, Tolerability, Preliminary Antitumor Activity, Pharmacokinetics, and Pharmacodynamics of VIP943 Monotherapy in Subjects With Advanced CD123+ Hematologic Malignancies
Learn more
  • Antibody Drug Conjugate (ADC)
  • Kinesin Spindle Protein (KSP) Inhibitor
  • CD123
  • Phase 1

Accepting patients

LP-118

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Leukemia (AML, ALL), MDS, MDS/MPN, and MF
Learn more
  • BCL-2 Inhibitor
  • Bcl/xL Inhibitor
  • Phase 1